TXG 10x Genomics, Inc.

TSX
$77.28

10x Genomics, Inc. (TXG) Institutional Ownership

What the institutions did with TXG last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended September 30, 2026.

Managers compared
3
filed both this quarter and last
Managers holding
3
+1 on the quarter
Buyers
2
1 opened new
Sellers
1
0 sold out entirely
Buyer share
66.7%
of managers who traded it
Breadth
+33.3
net buyers, as a share of those trading

Only 3 managers reported a position this quarter, so the percentages above describe a very small sample.

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
Versant Capital Management, Inc 18.2K 97.4%
MassMutual Private Wealth & Trust, FSB 484 2.6%
GoalVest Advisory LLC 10 0.1%

Largest changes

Manager Action Previous Current Change
Versant Capital Management, Inc Reduced 29.6K 18.2K -11.4K
MassMutual Private Wealth & Trust, FSB Increased 410 484 +74
GoalVest Advisory LLC New 0 10 +10

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.